Navigation Links
New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the World's Leading Bioenergetics Researchers
Date:5/29/2009

role of mitochondria in conditions such as neurodegeneration."

"Moving from 50 year old Clark electrodes to the XF technology will greatly advance our understanding of cellular bioenergetics," added Martin Brand. "It is essential that scientists understand how to use this new technology to its fullest capabilities and how to properly interpret these types of data. David Nicholls and I are committed to seeing cellular bioenergetics grow from a specialty field to a broad area of study."

Seahorse plans additional Cellular Bioenergetics Workshops enabling new discoveries on the role of cellular bioenergetics in cancer, ageing, obesity, diabetes, cardiovascular disease and toxicology, Visit www.seahorsebio.com for details.

About Workshop Leaders

Dr. David Nicholls is Professor of Mitochondria Physiology the Buck Institute for Age Research specializing in mitochondrial dysfunction. He is also a visiting Professor in the Dept. of Experimental Brain Research and Diabetes Centre at the University of Lund Sweden. Dr. Nicholls is widely recognized for insightful research that has kept him at the forefront of mitochondrial physiology his entire career. Most recently he has focused on studying bioenergetics in intact cells, specifically in neurons in order to understand life and death decisions that are pathologic in neurodegenerative diseases. His lab's focus on putting bioenergetics in the context of living cells is necessary in order to gain a better understanding of these dynamic and integrated systems. The laboratory is a world-leader in this area.

Dr. Martin Brand is Professor of Cellular Bioenergetics and Director of the Morphology core at the Buck Institute for Age Research and a Group Leader for the MRC Mitochondrial Biology Unit in Cambridge, UK. Dr. Brand is widely regarded as one of the leading authori
'/>"/>

SOURCE Seahorse Bioscience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
2. EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference
3. National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications
4. Chris Tihansky Appointed President of In Vivo Cellular Imaging Leader Cellvizio Inc.
5. First Live U.S. Demonstration of Cellvizio GI In Vivo Cellular Imaging Technology to Occur at Johns Hopkins Conference
6. Cellular construction methods emulated
7. Having Penetrated Israels Domestic Telephony Market, 012 Smile.Communications Prepares for Its Next Goal: Entering Israels Cellular Market
8. Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
9. New insights into cellular reprogramming revealed by genomic analysis
10. Cellumen to Collaborate With the NCTR of the FDA to Apply Cellular Systems Biology (CSB(TM)) to Predictive Toxicology
11. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014 Ophthalmic drug delivery ... and challenging endeavors as the anatomy, physiology and ... to the foreign substances. Ocular drug delivery technologies ... medication and minimal use of needles; also it ... and provides specific targeting within the ocular globe. ...
(Date:8/22/2014)... Los Angeles (PRWEB) August 22, 2014 ... for age-defying products, is in the spotlight again. ... night cream and its NeriumFirmTM Body Contouring Cream ... presented by Backstage Creations during the 66th Primetime ... the patented NAE-8® extract, third-party clinical trials show ...
(Date:8/21/2014)... Finnish-Swedish research group at the Institute for Molecular ... institutet, Stockholm, has developed a novel "man and ... This innovative diagnostic aid was described in ... The method is based on computer vision algorithms ... combined with visualization of only the diagnostically most ...
(Date:8/21/2014)... COLD SPRING, N.Y. , Aug. 21, 2014 ... today the launch of their Nutraceutical "TELO-20 for ... first and only Telomere-lengthening supplement in the world ... the ends of every chromosome in the body. ... the world,s leading experts in Telomere Science and ...
Breaking Biology Technology:Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 2Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 3A novel 'man and machine' decision support system makes malaria diagnostics more effective 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 3
... , , , ... SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical ... care of adults with Attention-Deficit/Hyperactivity Disorder (ADHD), a psychiatric behavioral ... country.* The first initiative, "RoADHD Trip," a multi-city self ...
... Aug. 17 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN ... letter from the Listing Qualifications Department of The NASDAQ ... with Listing Rule 5550(a)(2). , We plan to request ... Panel") to review the NASDAQ,s determination of the continued ...
... Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) ... therapy and oncology, today reported Phase 3 results for ... trial Z-041 in benign prostatic hyperplasia (BPH), with its ... on March 6, 2009, sanofi-aventis U.S. LLC entered into ...
Cached Biology Technology:Shire Initiates Two Adult ADHD Outreach Programs 2Shire Initiates Two Adult ADHD Outreach Programs 3Shire Initiates Two Adult ADHD Outreach Programs 4Vasogen Receives NASDAQ Notification Related to Minimum Bid Price 2AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 3AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 4AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 5AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 6AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 7
(Date:8/21/2014)... they are the ultimate source of all organic matter ... on algae, too, to suck up climate-warming carbon dioxide ... of the ocean. Now, by using a combination of ... that viruses infecting those algae are driving the life-and-death ... stays essentially the same, and this has important implications ...
(Date:8/21/2014)... In a finding that has implications for life in ... in the solar system, LSU Associate Professor of Biological ... National Science Foundation, or NSF, this week published a ... lake that lies 800 meters (2600 feet) beneath the ... microbial ecosystems.", Given that more than 400 subglacial lakes ...
(Date:8/21/2014)... connectors, designed by an international standards process, will be ... to an invited review published in the OnlineFirst version ... ), the official journal of the American Society for ... greatly reduce the occurrence of misconnection that can be ... which are used to join medical devices, components, and ...
Breaking Biology News(10 mins):Viruses take down massive algal blooms, with big implications for climate 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 3800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 4New feeding tube connectors will improve patient safety 2
... NARRAGANSETT, R.I. August 30, 2010 ... at the University of Rhode Island Graduate School ... Science Foundation (NSF) RAPID Response grant through the ... $199,909 NSF grant, Improving Communication of Oil Spill ...
... Undergrads often take communication courses unrelated to their major ... teamed up with the Library and English Departments to ... and understand literature searchers and incorporate them into papers ... and Gail R. Nonnecke, Iowa State University faculty from ...
... diseases are hereditary. But despite significant progress in genome ... The discovery of the underlying genetic defect is, however, ... of innovative approaches to their treatment. Scientists at the ... of Medical Genetics at the Charit Universittsmedizin - Berlin ...
Cached Biology News:Metcalf Institute wins NSF grant to help journalism and communication of oil spill research 2Teaching communication and information literacy skills 2All genes in 1 go 2
... The SlowFade Light Antifade Kit is ... photobleaching seen with fluorescent dyes. This formulation ... fluorescein AMCA and Cascade Blue fluorophores that ... (S-2828). This kit is available with the ...
Human Xg Affinity Purified Polyclonal Ab Keywords: Xg glycoprotein, hereditary hemorrhagic telangiectasia Protein Family: ...
in vitro Translation, Accessory Products...
...
Biology Products: